Y mAbs Therapeutics (YMAB) Insider Transactions
13.61 ↓3.60 (-20.92%)
As of May 8, 2024, 3:59pm EST.
Insider Transactions
| Transaction Date | Owner | Role | Action | Price | Total | Shares Remaining | Price Since | Source |
|---|---|---|---|---|---|---|---|---|
| 2021-07-06 | Bo Kruse | CFO | Sold 4 Shares | $34.15 | $137 | 0 | -60.15% | Link |
| 2021-06-22 | Bo Kruse | CFO | Sold 4 Shares | $36.17 | $145 | 245 | -62.37% | Link |
| 2021-06-14 | Thomas Gad | Insider | Sold 4 Shares | $35.8 | $143 | 0 | -61.98% | Link |
| 2021-06-09 | Biotech Aps Wg | Director | Sold 116 Shares | $36.19 | $4,198 | 4 | -62.39% | Link |
| 2021-06-07 | Biotech Aps Wg | Major Shareholder | Sold 72 Shares | $34.15 | $2,459 | 4 | -60.15% | Link |
| 2021-06-04 | Biotech Aps Wg | Major Shareholder | Sold 3 Shares | $34.03 | $102 | 4 | -60.01% | Link |
| 2021-06-04 | Bo Kruse | CFO | Sold 4 Shares | $33.48 | $134 | 249 | -59.35% | Link |
| 2021-06-03 | Johan Wedell-Wedellsborg | Director | Sold 30 Shares | $33.19 | $996 | 4 | -58.99% | Link |
| 2021-06-01 | Johan Wedell-Wedellsborg | Director | Sold 6 Shares | $35.57 | $213 | 4 | -61.74% | Link |
| 2021-05-28 | Thomas Gad | Insider | Sold 4 Shares | $36.95 | $148 | 0 | -63.17% | Link |
| 2021-05-28 | Johan Wedell-Wedellsborg | Director | Sold 25 Shares | $36.34 | $909 | 4 | -62.55% | Link |
| 2021-05-24 | Bo Kruse | CFO | Sold 4 Shares | $35.61 | $142 | 253 | -61.78% | Link |
| 2021-05-18 | Thomas Gad | Insider | Sold 4 Shares | $34.07 | $136 | 0 | -60.05% | Link |
| 2021-04-26 | Thomas Gad | Insider | Sold 7 Shares | $27.96 | $196 | 7 | -51.32% | Link |
| 2021-04-12 | Thomas Gad | Insider | Sold 7 Shares | $26.61 | $186 | 7 | -48.85% | Link |
| 2021-03-15 | Thomas Gad | Insider | Sold 7 Shares | $36.79 | $258 | 7 | -63.01% | Link |
| 2021-01-19 | Thomas Gad | Insider | Sold 7 Shares | $46.51 | $326 | 7 | -70.74% | Link |
| 2021-01-19 | David N Gill | Director | Sold 2 Shares | $46.52 | $93 | 2 | -70.74% | Link |
| 2021-01-05 | Thomas Gad | Insider | Sold 7 Shares | $49.36 | $346 | 7 | -72.43% | Link |
| 2020-12-28 | Thomas Gad | Insider | Sold 7 Shares | $51.98 | $364 | 7 | -73.82% | Link |
| 2020-12-16 | Thomas Gad | Insider | Sold 7 Shares | $53.01 | $371 | 7 | -74.33% | Link |
| 2020-12-14 | Thomas Gad | Insider | Sold 4 Shares | $52.89 | $212 | 0 | -74.27% | Link |
| 2020-12-10 | Thomas Gad | Insider | Sold 50 Shares | $50.75 | $2,538 | 50 | -73.18% | Link |
| 2020-12-02 | Pedro Claus Juan Moller-San | CEO | Sold 40 Shares | $51.27 | $2,051 | 15 | -73.45% | Link |
| 2020-12-02 | Vignesh Rajah | CMO | Bought 233 Shares | $51.03 | $11,890 | 0 | -73.33% | Link |
| 2020-12-01 | Thomas Gad | Chairman | Sold 4 Shares | $51.42 | $206 | 0 | -73.53% | Link |
| 2020-11-17 | Vignesh Rajah | CMO | Bought 1 Shares | $45.74 | $46 | 0 | -70.24% | Link |
| 2020-11-03 | David N Gill | Director | Sold 4 Shares | $45 | $180 | 4 | -69.76% | Link |
| 2020-10-15 | Thomas Gad | Chairman | Sold 4 Shares | $39.15 | $157 | 0 | -65.24% | Link |
| 2020-10-01 | Thomas Gad | Chairman | Sold 4 Shares | $38.88 | $156 | 0 | -64.99% | Link |
| 2020-09-14 | Thomas Gad | Chairman | Sold 22 Shares | $41 | $902 | 13 | -66.80% | Link |
| 2020-09-11 | Thomas Gad | Chairman | Sold 13 Shares | $40.33 | $524 | 13 | -66.25% | Link |
| 2020-09-01 | Thomas Gad | Chairman | Sold 4 Shares | $41.6 | $166 | 0 | -67.28% | Link |
| 2020-08-17 | Thomas Gad | Chairman | Sold 4 Shares | $40.35 | $161 | 0 | -66.27% | Link |
| 2020-08-11 | Thomas Gad | Chairman | Sold 37 Shares | $40.06 | $1,482 | 0 | -66.03% | Link |
$YMAB Like if the Hedgies are fucked
$YMAB let’s go baby!
$YMAB hang tight
ignore fud and buy dips if you can
everyone be okay????
$YMAB buy and hold and get rewarded
$YMAB buy more doomers!!!
$YMAB just fucking go already jeesh
$YMAB bears haha
$YMAB always with good potential for a long term Hodl
$YMAB Very bullish action
$YMAB we just getting started